Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines

Pharmacogenomics

Volumn 10, Issue 4, 2009, Pages 549-563

  Duan, Shiwei ^a   Huang, R Stephanie ^a   Zhang, Wei ^a   Mi, Shuangli ^a   Bleibel, Wasim K ^a   Kistner, Emily O ^a   Cox, Nancy J ^a   Dolan, M Eileen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Alternative splicing; Folate; Gene expression; HapMap

Indexed keywords

FOLIC ACID; FOLYLPOLYGLUTAMATE SYNTHASE;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ARTICLE; ASCC3L1 GENE; ATP13A2 GENE; CAUCASIAN; CONTROLLED STUDY; DDX52 GENE; ETHNIC DIFFERENCE; EXON; FOLATE METABOLISM; FPGS GENE; GENE; GENE EXPRESSION REGULATION; GENE PROBE; GENETIC MARKER; GENETIC TRANSCRIPTION; GENOTYPE; HAPLOTYPE MAP; HUMAN; HUMAN CELL; IFIH1 GENE; LYMPHOBLASTOID CELL LINE; NEGRO; POPULATION GENETICS; QUANTITATIVE TRAIT LOCUS; RUVBL2 GENE; SETX GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMARCA2 GENE; SMARCA5 GENE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALTERNATIVE SPLICING; CELL LINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLIC ACID; GENE EXPRESSION PROFILING; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION;

EID: 66849122225     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.09.8     Document Type: Article

References (42)

1. Djukic A: Folate-responsive neurologic diseases. Pediatr. Neurol. 37, 387-397 (2007).
2. Beaudin AE, Stover PJ: Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression. Birth Defects Res. C. Embryo Today 81, 183-203 (2007).
3. Boyles AL, Wilcox AJ, Taylor JA et al.: Folate and one-carbon metabolism gene polymorphisms and their associations with oral facial clefts. Am. J. Med. Genet. A. 146A, 440-449 (2008).
4. Jamieson JA, Kuhnlein HV. The paradox of anemia with high meat intake: a review of the multifactorial etiology of anemia in the Inuit of North America. Nutr. Rev. 66, 256-271 (2008).
5. Grzelakowska-Sztabert B, Zielinska ZM: The transfer of one-carbon units in insect metabolism. Pathways of folate coenzyme synthesis. J. Insect. Physiol. 13, 1207-1219 (1967).
6. Ranganathan P, Culverhouse R, Marsh S et al.: Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J. Rheumatol. 35, 572-579 (2008).
7. Sokka T, Envalds M, Pincus T: Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs. Mod. Rheumatol. 18, 228-239 (2008).
8. Stankova J, Lawrance AK, Rozen R: Methylenetetrahydrofolate reductase (MTHFR): a novel target for cancer therapy. Curr. Pharm. Des. 14, 1143-1150 (2008).
9. Robien K, Boynton A, Ulrich CM: Pharmacogenetics of folate-related drug targets in cancer treatment. Pharmacogenomics 6, 673-689 (2005).
10. Assaraf YG: Molecular basis of antifolate resistance. Cancer Metastasis Rev. 26, 153-181 (2007).
11. Wessels JA, van der Kooij SM, le Cessie S et al.: A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis Rheum. 56, 1765-1775 (2007).
12. Hsu DS, Balakumaran BS, Acharya CR et al.: Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J. Clin. Oncol. 25, 4350-4357 (2007).
13. Kager L, Cheok M, Yang W et al.: Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics: J. Clin. Invest. 115, 110-117 (2005).
14. Sorich MJ, Pottier N, Pei D et al.: In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile. PLoS Med. 5, E83 (2008).
15. Stranger BE, Nica AC, Forrest MS et al.: Population genomics of human gene expression. Nat. Genet. 39, 1217-1224 (2007).
16. Duan S, Huang RS, Zhang W et al.: Genetic architecture of transcript-level variation in humans. Am. J. Hum. Genet. 82, 1101-1113 (2008).
17. Zhang W, Duan S, Kistner EO et al.: Evaluation of genetic variation contributing to differences in gene expression between populations. Am. J. Hum. Genet. 82, 631-640 (2008).
18. Stranger BE, Forrest MS, Dunning M et al.: Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848-853 (2007).
19. Ford ES, Bowman BA: Serum and red blood cell folate concentrations, race, and education: findings from the third National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 69, 476-481 (1999).
20. Hao L, Ma J, Stampfer MJ et al.: Geographical, seasonal and gender differences in folate status among Chinese adults. J. Nutr. 133, 3630-3635 (2003).
21. Frazer KA, Ballinger DG, Cox DR et al.: A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851-861 (2007).
22. Huang RS, Duan S, Shukla SJ et al.: Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am. J. Hum. Genet. 81, 427-437 (2007).
23. Huang RS, Duan S, Bleibel WK et al.: A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc. Natl Acad. Sci. USA 104, 9758-9763 (2007).
24. Duan S, Zhang W, Bleibel WK, Cox NJ, Dolan ME: SNPinProbe_1.0: a database for filtering out probes in the Affymetrix GeneChip(R) Human Exon 1.0 ST array potentially affected by SNPs. Bioinformation 2(10), 469-470 (2008).
25. Affymetrix Inc.: Identifying and validating alternative splicing events. Affymetrix Technical Note (2006).
26. Abecasis GR, Cardon LR, Cookson WO: A general test of association for quantitative traits in nuclear families. Am. J. Hum. Genet. 66, 279-292 (2000).
27. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M: The KEGG resource for deciphering the genome. Nucleic Acids Res. 32, D277-D280 (2004).
28. Lawrence JM, Watkins ML, Chiu V, Erickson JD, Petitti DB: Do racial and ethnic differences in serum folate values exist after food fortification with folic acid? Am. J. Obstet. Gynecol. 194, 520-526 (2006).
29. Maniatis T, Tasic B: Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418, 236-243 (2002).
30. Kwan T, Benovoy D, Dias C et al.: Heritability of alternative splicing in the human genome. Genome Res. 17, 1210-1218 (2007).
31. Krajinovic M, Moghrabi A: Pharmacogenetics of methotrexate. Pharmacogenomics 5, 819-834 (2004).
32. Kent WJ, Sugnet CW, Furey TS et al.: The human genome browser at UCSC. Genome Res. 12(6), 996-1006 (2002).
33. Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR: A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc. Natl Acad. Sci. USA 104, 13513-13518 (2007).
34. Glinsky GV. Phenotype-defining functions of multiple non-coding RNA pathways. Cell Cycle 7, 1630-1639 (2008).
35. Faustino NA, Cooper TA: Pre-mRNA splicing and human disease. Genes Dev. 17, 419-437 (2003).
36. Brinkman BM: Splice variants as cancer biomarkers. Clin. Biochem. 37, 584-594 (2004).
37. Novoyatleva T, Tang Y, Rafalska I, Stamm S: Pre-mRNA missplicing as a cause of human disease. Prog. Mol. Submit Biol. 44, 27-46 (2006).
38. van Guelpen B: Folate in colorectal cancer, prostate cancer and cardiovascular disease. Scand. J. Clin. Lab. Invest. 67, 459-473 (2007).
39. Mattson MP, Shea TB: Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 26, 137-146 (2003).
40. Sharp L, Little J: Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am. J. Epidemiol. 159, 423-443 (2004).
41. Liu T, Soong SJ, Wang X, Wilson NP, Craig CB: African-American and white differences in nutritional status among low-income women attending public health clinics. J. Health Care Poor Underserved 7, 323-337 (1996).
42. Estrada DA, Billett HH: Racial variation in fasting and random homocysteine levels. Am. J. Hematol. 66, 252-256 (2001).